The performance of the GAP model in patients with rheumatoid arthritis associated interstitial lung disease

Respiratory Medicine

Volumn 127, Issue , 2017, Pages 51-56

  Morisset, Julie ^a   Vittinghoff, Eric ^a   Lee, Bo Young ^b   Tonelli, Roberto ^c   Hu, Xiaowen ^d   Elicker, Brett M ^a   Ryu, Jay H ^d   Jones, Kirk D ^a   Cerri, Stefania ^c   Manfredi, Andreina ^c   Sebastiani, Marco ^c   Gross, Andrew J ^a   Ley, Brett ^a   Wolters, Paul J ^a   King, Talmadge E ^a   Kim, Dong Soon ^b   Collard, Harold R ^a   Lee, Joyce S ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b University of Ulsan   (South Korea)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^d MAYO CLINIC   (United States)

^e UNIVERSITY OF COLORADO   (United States)

Author keywords

Interstitial lung disease; Prognosis; Rheumatoid arthritis; Risk assessment

Indexed keywords

AZATHIOPRINE; CARBON MONOXIDE; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; ETANERCEPT; HYDROXYCHLOROQUINE; LEFLUNOMIDE; METHOTREXATE; MYCOPHENOLATE MOFETIL; PREDNISONE; RHEUMATOID FACTOR; RITUXIMAB;

ADULT; AGE; ARTICLE; BODY MASS; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; FORCED VITAL CAPACITY; GENDER; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INTERSTITIAL LUNG DISEASE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY RISK; OXYGEN THERAPY; PHYSIOLOGY; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; STRUCTURED QUESTIONNAIRE; AGED; COMPLICATION; DIAGNOSTIC IMAGING; FIBROSING ALVEOLITIS; HEALTH STATUS INDICATOR; METABOLISM; MORTALITY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROGNOSIS; VITAL CAPACITY; X-RAY COMPUTED TOMOGRAPHY;

AGED; ARTHRITIS, RHEUMATOID; CARBON MONOXIDE; FEMALE; HEALTH STATUS INDICATORS; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; INCIDENCE; LONGITUDINAL STUDIES; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; VITAL CAPACITY;

EID: 85018782822     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2017.04.012     Document Type: Article

References (29)

1. [1] Gabriel, S.E., The epidemiology of rheumatoid arthritis. Rheum. Dis. Clin. North Am. 27:2 (2001), 269–281.
2. [2] Turesson, C., O'Fallon, W.M., Crowson, C.S., Gabriel, S.E., Matteson, E.L., Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years. Ann. Rheum. Dis. 62:8 (2003), 722–727.
3. [3] Turesson, C., Eberhardt, K., Jacobsson, L.T., Lindqvist, E., Incidence and predictors of severe extra-articular disease manifestations in an early rheumatoid arthritis inception cohort. Ann. Rheum. Dis. 66:11 (2007), 1543–1544.
4. [4] Hochberg, M.C., Johnston, S.S., John, A.K., The incidence and prevalence of extra-articular and systemic manifestations in a cohort of newly-diagnosed patients with rheumatoid arthritis between 1999 and 2006. Curr. Med. Res. Opin. 24:2 (2008), 469–480.
5. [5] Bongartz, T., Nannini, C., Medina-Velasquez, Y.F., et al. Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study. Arthritis Rheum. 62:6 (2010), 1583–1591.
6. [6] Olson, A.L., Swigris, J.J., Sprunger, D.B., et al. Rheumatoid arthritis-interstitial lung disease-associated mortality. Am. J. Respir. Crit. Care Med. 183:3 (2011), 372–378.
7. [7] Picchianti Diamanti, A., Germano, V., Bizzi, E., Lagana, B., Migliore, A., Interstitial lung disease in rheumatoid arthritis in the era of biologics. Pulm. Med., 2011, 2011, 931342.
8. [8] Brown, K.K., Rheumatoid lung disease. Proc. Am. Thorac. Soc. 4:5 (2007), 443–448.
9. [9] Kim, E.J., Collard, H.R., King, T.E. Jr., Rheumatoid arthritis-associated interstitial lung disease: the relevance of histopathologic and radiographic pattern. Chest 136:5 (2009), 1397–1405.
10. [10] Wolfe, F., Caplan, L., Michaud, K., Rheumatoid arthritis treatment and the risk of severe interstitial lung disease. Scand. J. Rheumatol. 36:3 (2007), 172–178.
11. [11] Dixon, W.G., Hyrich, K.L., Watson, K.D., Lunt, M., Symmons, D.P., Influence of anti-TNF therapy on mortality in patients with rheumatoid arthritis-associated interstitial lung disease: results from the British society for rheumatology biologics register. Ann. Rheum. Dis. 69:6 (2010), 1086–1091.
12. [12] Kim, E.J., Elicker, B.M., Maldonado, F., et al. Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease. Eur. Respir. J. 35:6 (2010), 1322–1328.
13. [13] Koduri, G., Norton, S., Young, A., et al. Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an inception cohort. Rheumatol. Oxf. 49:8 (2010), 1483–1489.
14. [14] Solomon, J.J., Ryu, J.H., Tazelaar, H.D., et al. Fibrosing interstitial pneumonia predicts survival in patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD). Respir. Med. 107:8 (2013), 1247–1252.
15. [15] Solomon, J.J., Chung, J.H., Cosgrove, G.P., Demoruelle, M.K., Fernandez-Perez, E.R., Fischer, A., et al. Predictors of mortality in rheumatoid arthritis-associated interstitial lung disease. Eur. Respir. J. 47:2 (2016), 588–596.
16. [16] Assayag, D., Lubin, M., Lee, J.S., King, T.E., Collard, H.R., Ryerson, C.J., Predictors of mortality in rheumatoid arthritis-related interstitial lung disease. Respirology 19:4 (2014), 493–500.
17. [17] Park, J.H., Kim, D.S., Park, I.N., et al. Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes. Am. J. Respir. Crit. Care Med. 175:7 (2007), 705–711.
18. [18] Tanaka, N., Kim, J.S., Newell, J.D., et al. Rheumatoid arthritis-related lung diseases: CT findings. Radiology 232:1 (2004), 81–91.
19. [19] Tsuchiya, Y., Takayanagi, N., Sugiura, H., et al. Lung diseases directly associated with rheumatoid arthritis and their relationship to outcome. Eur. Respir. J. 37:6 (2011), 1411–1417.
20. [20] Ley, B., Ryerson, C.J., Vittinghoff, E., et al. A multidimensional index and staging system for idiopathic pulmonary fibrosis. Ann. Intern. Med. 156:10 (2012), 684–691.
21. [21] Arnett, F.C., Edworthy, S.M., Bloch, D.A., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31:3 (1988), 315–324.
22. [22] Raghu, G., Collard, H.R., Egan, J.J., et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am. J. Respir. Crit. care Med. 183:6 (2011), 788–824.
23. [23] Kim, E.S., Choi, S.M., Lee, J., et al. Validation of the GAP score in Korean patients with idiopathic pulmonary fibrosis. Chest 147:2 (2015), 430–437.
24. [24] Ryerson, C.J., O'Connor, D., Dunne, J.V., et al. Predicting mortality in systemic sclerosis-associated interstitial lung disease using risk prediction models derived in idiopathic pulmonary fibrosis. Chest, 2015.
25. [25] Ryerson, C.J., Vittinghoff, E., Ley, B., et al. Predicting survival across chronic interstitial lung disease: the ILD-GAP model. Chest 145:4 (2014), 723–728.
26. [26] Nakamura, Y., Suda, T., Kaida, Y., et al. Rheumatoid lung disease: prognostic analysis of 54 biopsy-proven cases. Respir. Med. 106:8 (2012), 1164–1169.
27. [27] Lee, H.K., Kim, D.S., Yoo, B., et al. Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease. Chest 127:6 (2005), 2019–2027.
28. [28] Assayag, D., Elicker, B.M., Urbania, T.H., et al. Rheumatoid arthritis-associated interstitial lung disease: radiologic identification of usual interstitial pneumonia pattern. Radiology 270:2 (2014), 583–588.
29. [29] Chehata, J.C., Hassell, A.B., Clarke, S.A., et al. Mortality in rheumatoid arthritis: relationship to single and composite measures of disease activity. Rheumatol. Oxf. 40:4 (2001), 447–452.